Selected article for: "cc NC ND International license and complicated disease"
Author: Eric Anthony Coomes; Hourmazd Haghbayan
Title: Interleukin-6 in COVID-19: A Systematic Review and Meta-Analysis
  • Document date: 2020_4_3
    • ID: nadcsiii_46
    Snippet: In this systematic review and meta-analysis, we demonstrate serum levels of IL-6 to be significantly elevated in the setting of complicated COVID-19 disease, and increased IL-6 levels to be in turn significantly associated with adverse clinical outcomes. This suggests that the . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity......
    Document: In this systematic review and meta-analysis, we demonstrate serum levels of IL-6 to be significantly elevated in the setting of complicated COVID-19 disease, and increased IL-6 levels to be in turn significantly associated with adverse clinical outcomes. This suggests that the . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • adverse clinical outcome and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adverse clinical outcome and International license: 1
    • adverse clinical outcome and meta analysis: 1, 2, 3, 4, 5
    • adverse clinical outcome and serum level: 1
    • cc NC ND International license and clinical outcome: 1, 2, 3, 4, 5, 6, 7
    • cc NC ND International license and complicated disease: 1, 2
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and meta analysis: 1, 2, 3, 4, 5, 6
    • cc NC ND International license and serum level: 1, 2, 3, 4
    • clinical outcome and complicated disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical outcome and International license: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical outcome and meta analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical outcome and serum level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • complicated disease and International license: 1, 2
    • complicated disease and meta analysis: 1, 2, 3, 4, 5, 6, 7, 8
    • complicated disease and serum level: 1
    • International license and meta analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • International license and serum level: 1, 2, 3, 4
    • meta analysis and serum level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14